TP53 and cancer: Mutations in TP53 occur frequently in several cancer types, including NSCLC (Cote et al., 2011; Bollig-Fischer et al., 2015; Arbour et al., 2018; Arauz et al., 2020; Cheng et al., 2020; Huang et al., 2020; Fan et al., 2022).